Our most popular links (they might take a few seconds to load - they're worth the wait!):



UPDATE 6-Glaxo boosted by drug comebacks, Q1 earnings


UPDATE 6-Glaxo boosted by drug comebacks, Q1 earnings

home   >   MSN news

market by the middle of this year after signing a legal agreement with regulators over a problem plant in Puerto Rico. ... beating 17 percent rise in first-quarter earnings, driven by strong sales of asthma drug Advair and Avandia for diabetes ...

- link to UPDATE 6-Glaxo boosted by drug comebacks, Q1 earnings -
Last update: 05/26/2005


Recommended Reading

    Advair diskus 250/50.(New & Approved) : An article from: Internal Medicine News
    Advair Diskus 250/50.(New & Approved) : An article from: Family Practice News
    Advair diskus 250/50.(New & Approved) : An article from: Internal Medicine News
    New and approved: Nasacort HFA Nasal Aerosol, Advair Diskus.(Rx) : An article from: Family Practice News
    Advair Diskus.(New & Approved) : An article from: Pediatric News
    Advair beats combivent for patients with COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) : An article from: Internal Medicine News
    Advair Diskus 250/50.(New & Approved) : An article from: Family Practice News
    Advair beats combivent for patients with COPD.(Pulmonary Medicine)(chronic obstructive pulmonary disease) : An article from: Internal Medicine News